SOAT1 and acute lymphoblastic leukemia: The limitations of this study include the need to refine measures of body mass and fat, to have cohorts of patients with longer follow-up to obtain more reliable survival calculations, and to perform transcriptome sequencing that will allow us to know the alterations associated with ALL Ph-like and the subgroup of patients with an aberrant Jak-Stat pathway.